Transplantation is normally suggested in cases of aggressive, high-risk, or recurrent cancers, which take place after normal chemotherapy. In patients with remitting AML or ALL, or those with refractory Lymphoma, a transplant is the most effective opportunity of a long-term cure, and experts carefully consider the individual disease history of every patient to decide the most appropriate time to undergo such a procedure.